Seo Bachem's Strong H1 2026 le Lilemo Tse Leshome Li Khutlisetsa Molemo bakeng sa Mmaraka oa Peptide CDMO
Ha Bachem Holdings AG e lokolla chelete ea eona H1 2026 tlaleho ea lichelete, lipalo li fane ka mokhoa o fetang hole oa ntlafatso ea kotara bakeng sa bahlahlobisisi ba tekano. Ka thekiso ea lihlopha e fihlang ho CHF 326.4 milione (+7.3% kholo ea lichelete tsa lehae) le thekiso ea merero ea kliniki karolong ea eona ea ntlafatso ea CMC +39.5% ka lichelete tsa lehae ho CHF 167.5 milione, k'hamphani e bontšitse lebelo le leholo la tlhoko ea hajoale ea biopharmaceutical. E tšehelitsoe ke tataiso ea kholo ea chelete ea selemo e felletseng ea kholo ea chelete e theohetse ho 35% -40% le ts'enyehelo ea chelete ea selemo kaofela. (CAPEX) moralo oa CHF 350 limilione ho CHF 400 milione, Boemo ba lichelete ba Bachem bo sebetsa e le moemeli ea hlakileng oa moruo oa lefatše lohle maraka oa peptide CDMO.
Bakeng sa li-biopharma C-suites, Baokameli ba Kalafo, le lihlooho tsa Khemistri, Tlhahiso, le Litaolo (CMC), ho bala liphetho tsena tsa lichelete ho hloka moralo oa phetolelo. Lichelete tse kopaneng tsa lilemo tse leshome tsa Bachem le likatoloso tse kholo tse ntseng li tsoela pele - joalo ka ts'ebetso ea khoebo ea Building K e Bubendorf le nts'etsopele ea greenfield e Sisslerfeld - e totobatsa 'nete ea meralo.: Motse-moholo oa lefats'e o kopanya li-blockbusters tsa khoebo tsa lithane tse ngata ho mafu a metabolic, glucagon-joaloka peptide-1 (GLP-1) li-agonists tsa li-receptor, le oligonucleotide therapeutics.
Leha ho le joalo, khatello ena ea mega-scale capital e na le litlamorao tse tebileng tsa ts'ebetso ho pholletsa le ketane ea phepelo. Joalo ka ha baetsi ba likonteraka tsa Tier-1 ba itlama ka bongata ho litumellano tsa phepelo ea khoebo ea lilemo tse ngata, Li-CDMO tsa boemo bo bohareng li tobane le phetoho e matla ea moeli, ha biotech ea ka tlung le pharma R&Lihlopha tsa D li kopana le linako tsa ho etella pele tse ntseng li eketseha le ho ba le bofokoli ba ho fana ka lipeipi tsa bobeli tsa bongaka. Ho lekola maemo ana a lichelete ho fana ka tlhaloso ea bohlokoa mabapi le ho fumaneha ha chelete, theko ea boleng, le moralo oa maemo a tšohanyetso a phepelo lefatšeng ka bophara.
Ho bala Bachem's Balance Sheet e le moemeli oa indasteri: Capital Intensity le Scale Thresholds
Ho utloisisa hore na ke hobane'ng maraka oa peptide CDMO e na le bothata bo boholo bo sa lekanyetsoang, motho o tlameha ho hlahloba mechanics ea balance sheet ea moetapele oa eona oa mmaraka. Ho aha le ho tšoaneleha lisebelisoa tsa tlhahiso ea lipeptide tsa khoebo e se e le e 'ngoe ea mesebetsi e kenyang chelete e ngata molemong oa ho etsa likonteraka tsa meriana..
Karolong ea pele ea 2026 feela, Bachem e tsetetse CHF 148.4 limillione tsa meaho ea tlhahiso ea lefats'e. Le ha chelete e kenang ho Nts'etsopele ea CMC e ile ea hola haholo ka lebaka la mananeo a morao-rao a kliniki, Thekiso ea khoebo ea API e theohetse ho CHF ka nakoana 133.0 milione (-19.3% ka lichelete tsa lehae), e bonts'ang liphetoho tsa kemiso ea sehlopha pele ho katoloso e felletseng ea khoebo ea Building K. Ka nako e le nngwe, Lebelo la EBITDA la Bachem le fetotsoe ho 25.4% (CHF 82.8 milione) ha ho bapisoa le 29.1% nakong ea selemo se fetileng.
Tsa lichelete & Lipontšo tsa Ts'ebetso (Bachem H1 2026 khahlano le. Impact Proxy Proxy)
Metric H1 2026 Phetolelo ea Limmaraka tsa Boleng e tlalehiloeng & Tlhaloso ea Ts'ebetso
Sehlopha Sales Net CHF 326.4M (+7.3% LC) Katoloso e tsitsitseng ea maemo a holimo ho pholletsa le tleliniki & LITLHAKISO tsa khoebo.
CMC Development Sales CHF 167.5M (+39.5% LC) Ketsahalo ea morao-rao ea liteko tsa tleliniki e nkang bokhoni bo khethehileng ba CDMO.
H1 CAPEX Investment CHF 148.4M Ho hlokahala hore ho kenngoe chelete esale pele bakeng sa lisutu tse phahameng tsa SPPS.
FY2026 E reriloeng CAPEX CHF 350M - 400M E Theha mokoallo oa lidolara tse limilione tse makholo ho kena ho Tier-1.
EBITDA Margin 25.4% (khahlano le. 29.1% pele) Litsenyehelo tse sa fetoheng le litefello tsa thuto ea setsi li hatella moeli oa nako e haufi.
Khatello ena ea nakoana ea EBITDA e senola 'nete ea mantlha mabapi le Solid-Phase Peptide Synthesis ea sejoale-joale. (SPSS): litšenyehelo tse tsitsitseng tsa ho phahamisa li ngata haholo. Pele ho ka lokolloa sehlopha se le seng sa khoebo se rarahaneng sa 30-40 amino acid peptide, bahlahisi ba tlameha ho monya lilemo tsa ho theoha ha chelete, thuto ea setsi, netefatso ya tikoloho, le basebetsi ba khethehileng ba tekheniki.
Joalokaha ho totobalitsoe ho tlhahlobo ea katoloso ea matla a lefatše a TIDES, ho fumaneha ha chelete lekaleng la CDMO ha ho sa ajoa ka ho lekana. E phalla ka ho khetheha ho bahlahisi ba khonang ho etsa lihlahisoa tsa selemo le selemo tsa lithane tse ngata. Bakeng sa lik'hamphani tsa biopharma tse bohareng le tse hlahang, sena sa capital dynamic se theha sebopeho sa mebaraka sa mekhahlelo e 'meli: Li-CDMO tsa Tier-1 li ntse li ntlafatsoa le ho feta bakeng sa likonteraka tsa khoebo tsa mega-volume, ho siea liphatlalatso tsa kliniki tse bohareng le tsa pele li qothisana lehlokoa le nako e lekanyelitsoeng e feto-fetohang ea reactor.
Ho qhekella libotlolo tsa Supply Chain: Lisebelisuoa tse ka Holimo ho ea Kamoreng e Hloekileng Tlatsa-Qetella
Le hoja litaba tsa indasteri ea sehlooho li tsepamisitse maikutlo ho molumo oa reactor, baetapele ba CMC ba nang le boiphihlelo ba hlokomela seo litšitiso tsa matla a ho etsa peptide pharalla mokhoa oohle oa ho phalla, ho tloha ho motsoako oa lik'hemik'hale ho ea ho khethollo ea ho qetela e sa hloekang.
Phepelo ea Lik'hemik'hale e Phahameng → Li-Suites tsa Synthesis Reactor → Tlhoekiso e Tlase → Lyophilization & Kamore e hloekileng
(Fmoc-Amino Acids / Li-resin) (SPSS / LPPS / Ho bela) (Prep-HPLC / Counterion) (Sehlopha 100 Ho behwa ka thoko & CoA)
Key Takeaway: Mathata a mantlha a matla tlhahisong ea li-peptide ha se hangata a lekanyetsoang ho bophahamo ba sebali. Mecha ea litaba ea ho itokisa ea HPLC e tlase, mekhoa ea ho tsosolosa solvent, le Sehlopha 100 Li-suite tsa ho itšehla thajana tse hloekileng li emela litšitiso tsa mantlha tsa lisebelisoa tsa boemo ba kliniki.
1. Mahlohonolo a Raw Material a Phahameng
Motsoako oa li-peptide tse rarahaneng o ipapisitse le motheo oa phepelo ea thepa e tala. Fetile 85% ea Fmoc ea lefats'e- le li-amino acid tse sirelelitsoeng ka Boc, li-resin tse khethehileng tse sebetsang (joalo ka Wang, Rink Amide, le li-resin tsa chlorotrityl), le li-reagents tse sebetsang hantle haholo tsa ho kopanya (MOHATO, PyBOP, HOBt) e tsoa ho palo e nyane ea bahlahisi ba lik'hemik'hale tse khethehileng. Ha mananeo a maholo a khoebo a GLP-1 a sebelisa lithane tse makholo tsa thepa e tala, linako tse etellang pele bakeng sa li-amino acid tse tloaelehileng kapa ts'ebetso e khethehileng ea resin e ka tloha ho 6 ho 12 likhoeli, ho theha likotsi tsa kemiso ea hang-hang bakeng sa merero e ikemetseng ea kliniki.
2. Linako Tse Tsoang Pele tsa Reactor ea Upstream
Li-reactor tsa SPPS tsa boemo ba indasteri (>1,000 lilithara) hloka boenjiniere bo rarahaneng ba sekepe sa khatello, mekhoa ea ho fana ka solvent e ikemetseng, le tse khethehileng tse thibelang ho phatloha (ATEX) tlhophiso ea kamore ea ho hlapela. Linako tsa pele tsa ho fumana le ho fana ka li-reactor tse ncha tse kholo tsa SPPS hajoale li pakeng tsa 18 le 36 likhoeli. Leha motse-moholo o bolokehile ka botlalo, ho kenya lisebelisoa tsa 'mele le mangolo a ts'ebetso li beha moeli o tiileng oa lebelo mabapi le hore na phepelo ea lefats'e e ka hola kapele hakae.
3. Downstream Purification le Counterion Exchange
Ts'ebetso e tlase e ntse e le bothata bo matla ba tekheniki ho itšehla thajana ha peptide. Ho latela maemo a tiileng a ho phunyeha le ho na ha peptide e tala, tlhoekiso e hloka ho itokisa ho khutlela morao-mohato o phahameng oa Ts'ebetso ea Liquid Chromatography (HPLC). Litšitiso tsa bohlokoa li kenyelletsa:
- Qeto ea Chromatographic (Rₛ): Ho arola tatellano e amanang haufi-ufi ea ho hlakola (joalo ka n-1 kapa n+1 truncation ditshila tse bakoang ke kopanyo e sa fellang) 'me li-diastereomer li hloka litšiea tse bophara bo boholo tse nang le silica e khethehileng ea C18 kapa C8.. Ka mohlala, ka li-analogue tsa ketane e telele tsa GLP-1 (>30 masalla), hydrophobic aggregation nakong ea ho palamisa e ka fokotsa haholo palo ea lipoleiti, e hloka li-gradients tse hlophisitsoeng tsa organic modifier ho rarolla li-isomers tse kopanyang.
- Pholiso ea Solvent: Ho hloekisa lithane tse ngata ho hloka boholo ba acetonitrile (ACN) le trifluoroacetic acid (TFA), e hlokang liindasteri tsa ho khutlisa solvent ho boloka tumellano ea tikoloho le taolo ea litšenyehelo tsa ts'ebetso.
- Phetoho ea Counterion: Ho fetolela matsoai a trifluoroacetate hore e be mefuta ea acetate kapa chloride e amohelehang ka meriana ho hloka mehato ea bobeli ea ion-exchange chromatography., ho eketsa nako ea ts'ebetso le tahlehelo e ka bang teng ea chai. Peptide Synthesis
4. Lyophilization le Sehlopha 100 Ho Ikhetha Kamoreng e Hloekileng
Li-peptide tse ngata tse sebetsang tsa meriana (APIs) e hloka ho omisa ho hoama ho hoholo (lyophilization) bokhoni ba ho theha botsitso ba nako e telele bo tiileng. Ho feta moo, bakeng sa metsoako ea batsoali, ho tshwara le ho paka ka bongata ho tlameha ho etsahala ho Sehlopha se netefaditsweng 100 (ISO 5) tikoloho ea likamore tse hloekileng ho felisa tšilafalo ea bioburden le endotoxin. Lisebelisoa tse haelloang ke Sehlopha se kopaneng ka botlalo 100 Likamore tse sa hloekang li tobane le litšitiso tse matla tsa taolo ha ho fetoloa thepa ho tloha ho synthesis ea laboratori ho ea qetellong ea tleliniki..
Theko Matla le Konteraka Lock-In: Melao e Mecha ea ho Kopanela
Ho se leka-lekane pakeng tsa tlhokeho e ntseng e eketseha ea kalafo le phepelo e haelloang ke chelete ho entse hore litheko tsa 'maraka li fetohe ho baetsi ba likonteraka.
Theko ea tlhahiso ea konteraka bakeng sa li-API tsa li-peptide tse phahameng tsa GLP-1 e eketsehile ka 25% ho 40% ho pholletsa le li-CDMO tse kholo ho tloha ka nako eo 2023. Ho feta theko ea motheo ea theko, sebopeho sa kontraka ea CDMO e na le
Moetsi oa Glp le Peptides Contracting Parameter Legacy CDMO Model (Pele ho 2023) Tekanyetso ea Mebaraka ea Kajeno (2026+)
leq>Contracting Parameter Legacy CDMO Model (Pele ho 2023) Tekanyetso ea Mebaraka ea Kajeno (2026+)
Boitlamo ba Bokhoni Spot-mmaraka & batch-by-batch lilemo tse 3 ho isa ho tse 5 tsa ho nka kapa ho lefa likonteraka tsa peeletso
Li-Deposit tsa Pehelo 10% - 20% mohato oa pele 40% - 50% boitlamo bo ka pele bo sa buseng
Tefiso ea Tech Transfer E nkiloeng kapa e theotsoe haholo E ka lefisoa ka ho feletseng ka liheke tsa bohlokoahali
Kemiso ea ho Flexibility matsatsi a 30 ho isa ho a 60 ho hlophisa bocha likotlo tse matla tsa ho hlakola & notletsoe
Lisebelisoa tse so ntlafatsoe
Li-CDMO tsa Tier-1 hajoale li batla litumellano tsa ho boloka bokhoni ba lilemo tse 3 ho isa ho tse 5 ka li-deposit tse ngata tse ke keng tsa buseletsoa.. Bakeng sa lik'hamphani tse kholo tsa meriana tse tšehelitsoeng ke li-franchise tsa khoebo tsa lidolara tse libilione, lipehelo tsena ke inshorense ea ts'ebetso e amohelehang. Leha ho le joalo, bakeng sa lifeme tsa boholo bo bohareng ba biotech tse tsamaisang liteko tsa bongaka tsa Mokhahlelo oa I/II, boitlamo bo sa tsitsang ba ho nka kapa ho lefa bo hlahisa kotsi e sa amoheleheng. Fektheri ea Gku Peptide
liteko tsohle, boitlamo bo sa tsitsang ba ho nka kapa ho lefa bo hlahisa kotsi e sa amoheleheng.
Ho fokotsa ts'ebetso ea ts'ebetso le ho fokotsa ts'ebetso, lihlopha tsa ho reka thepa li lokela ho ikamahanya le thuto ea barekisi le ICH Q7 Litaelo tsa Boitloaelo bo Botle ba Tlhahiso bakeng sa Metsoako e sebetsang ea Meriana. Ho hokahanya litumellano tsa boleng esale pele ho netefatsa hore li-CDMO tsa bobeli li kopana le litekanyetso tse thata tsa taolo ntle le ho tlisa phetiso e sa hlokahaleng ea theknoloji ha kabo ea kemiso e sa lebelloang ea Tier-1 e etsahala..
Ha setsi sa Tier-1 se na le kemiso e fetohang kapa se abela lisutu tsa reactor sebakeng sa khoebo, merero e menyenyane ea kliniki e kotsing ea ho behelloa ka thoko. Tikoloho ena e etsa hore ho itšetlehe ka motho a le mong, mega-scale CDMO e bohlokoa ts'ebetsong ea ts'oaetso bakeng sa liphaephe tse se nang li-blockbuster.
Litlamorao tsa Leano bakeng sa li-CDMO tsa Boemo bo Bohareng le In-House R&D lihlopha
Ho tsamaisa tikoloho ena ea mmaraka ho hloka maano a ts'ebetso a hlophisitsoeng ho latela hore na mokhatlo o fana ka lits'ebeletso tsa CDMO kapa o li rekela lipeipi tsa kahare..
Bakeng sa li-CDMO tsa Boemo bo Bohareng: Tlhokahalo ea Phapano
Baetsi ba likonteraka tsa mahareng ba ke ke ba hlola ntoa e tobileng ea capital khahlano le baetapele ba mebaraka ba lidolara tse libilione ba tsetelang CHF. 400 milione ka selemo ka bongata ba thepa ea SPPS. Ho leka ho aha maemo a maemo, Bokhoni ba ho kopanya thepa ea GLP-1 ntle le litumellano tse sirelelitsoeng tsa nako e telele tsa ho theola boima ba 'mele bo pepesetsa li-CDMO tsa maemo a mahareng khatellong e feteletseng ea marang-rang haeba phepelo ea mmaraka e tloaeleha..
Ho e-na le hoo, Li-CDMO tse atlehileng tsa maemo a mahareng li fumana maemo a holimo ka ho fapana ka botekgeniki:
- Liphetoho tse rarahaneng tsa Tatelano: Ho tseba k'hemistri e thata, ho kenyelletsa le libaesekele tse ngata tsa disulfide, lipidation e khethehileng sebakeng, PEGylation, kenyeletso e seng ea tlhaho ea amino acid, le ho ngola fluorescent (>300 mefuta e fapaneng ea lihlopha tse sebetsang).
- Litsela tsa Hybrid Synthesis: Ho kopanya SPPS ea setso le Liquid-Phase Peptide Synthesis (LPPS) fragment condensation kapa recombinant microbial fermentation ho eketsa chai e mpe bakeng sa li-peptide tse telele. (>40 li-amino acid).
- Bokhoni ba Agile Cleanroom: Ho fana ka potlako, Sehlopha 100 Cleanroom-compliant batch execution bakeng sa lisebelisoa tsa mohato oa kliniki, ho lumella batšehetsi ho feta mela ea peeletso ea Tier-1 ea lilemo tse ngata.
Bakeng sa In-House Biopharma R&D lihlopha: Nahana hape ka Sourcing & Merero ea Contingency
Bakeng sa lisebelisoa tsa biopharma, batsamaisi ba thepa, le R&D batsamaisi, Ho itšetleha ka mohloli o le mong ho CDMO ea Tier-1 ho emela kotsi e kholo ea phepelo. Ho phethahatsa ka katleho peptide phepelo ea tlhophiso ea maemo a tšohanyetso ho hloka ho theha teka-tekano, matrix a barekisi ba mefuta e mengata.
Setsi sa Meaho: Sehlopha sa 1 sa Khoebo vs. Agile Specialized Partner
Ho Fumana Karolo ea Pele ea Ts'ebetso e Lebeletsoeng e Ntle
Li-CDMO tsa Tier-1 Mega CDMOs Ho etsa lithane tse ngata tsa khoebo Li-blockbusters tse amohelehang tsa khoebo (Mokhahlelo oa III/Maraka)
Li-CDMO tsa Agile tse Khethehileng tsa bohloeki bo phahameng, Phase I/II lihlopha tsa kliniki, tatellano e thata,
Sehlopha 100 ho latela tlhapi, liphetoho tse rarahaneng, le maano a kopanelo a mabeli
phetiso e potlakileng ea theknoloji & ho phahamisa
Ka ho theha mofuta o bonolo oa ho fumana li-dual-sourcing pele ho nts'etsopele, batšehetsi ba boloka tebello e felletseng ea ts'ebetso. Le ha molekane oa Tier-1 a sebetsana le moralo oa nako e telele oa kholo ea khoebo, e matjato, molekane ea khethehileng o laola phepelo e potlakileng ea bongaka, tlhahlobo e rarahaneng ea phetoho, le tlhahiso ea bekapo ea tšohanyetso.
Ho fumana chelete & Contingency Playbook: Ho Aha Matla a Phepelo a Phepelo
Ho insulate mananeo a tleliniki ho tloha mebaraka ka bophara squeezes, biopharma R&Lihlopha tsa D li lokela ho etsa buka ea ho bapala ea mehato e meraro ea phepelo ea matla.
Mohato 1: Buffer ea Lintho tse ka Holimo → Mohato 2: Agile Dual-Sourcing Partner → Mohato 3: Analytical Transparency
(Tšoaneleha resin ea bobeli / amino acid) (Sehlopha 100 tlhahlobo ea kamore e hloekileng) (HPLC/MS e sa fetoheng & CoA)
Mohato 1: Upstream Raw Material Pre-Qualification
Le ka mohla u se lumelle CDMO ho itšetleha ka li-amino acid tse tšoanelehang tsa mohloli o le mong kapa li-resin tse khethehileng. Batšehetsi ba lokela ho itlhahloba ka boikemelo le ho tšoaneleha pele ho bafani ba thepa ea bobeli ea lefats'e bakeng sa Fmoc-amino acid e bohlokoa., ho kopanya li-reagents, le cleavage cocktails bonyane 12 ho 18 likhoeli pele o qala tlhahiso ea bohlokoa ea liteko tsa kliniki.
Mohato 2: Kopanya Molekane oa Agile Dual-Sourcing
Ho lumellana le motsoako o kopaneng oa peptide le sethala sa phetoho e fana ka inshorense ea hang-hang khahlano le tieho ea mantlha ea CDMO. Ha ho hlahlojoa balekane ba khethehileng ba bobeli, R&Lihlopha tsa D li tlameha ho netefatsa:
- Bohloeki le Sekala: Bokhoni ba ho fana ka bohloeki bo phahameng bo tiisitsoeng (≥98%) tatellano e eketseha ka mokhoa o sa reroang ho tloha ho milligram-level R&D ho hlahloba lihlopha tsa lifofane tsa lik'hilograma tse ngata.
- Tikoloho e Hloekileng ea Tlhahiso: E netefalitsoe Sehlopha 100 lisebelisoa tsa tlhahiso ea likamore tse hloekisitsoeng haholo ho felisa likotsi tsa ts'oaetso nakong ea ntlafatso ea tlhahiso.
- Phetoho Bophara: Setsebi sa tekheniki se pharalla 300 mefuta ea phetoho e tloaelehileng, ho kenyelletsa lipidation, stapling, le ho kopanya ha enzymatic.
Mohato 3: Kenya Tšebetso ea Ponaletso e Felletseng ea Analytical
Peptide Synthesis Botšepehi ba tlhahlobo ha bo ka buisanoa ha ho etsoa phetiso ea theknoloji lipakeng tsa barekisi ba mantlha le ba bobeli.. Tlas'a Ke Q2(R1) litataiso tsa netefatso ea tlhahlobo, batšehetsi ba tlameha ho hloka Setifikeiti se felletseng sa Analysis (CoA) litokomane bakeng sa sehlopha se seng le se seng, ho kenyeletsa:
- Li-chromatogram tsa Analytical HPLC tsa boemo bo holimo tse pakang liphesente tse hloekileng le qeto (Rₛ ≥ 1.5) ho tloha ditshila tse hlakotsweng tse bapileng.
- Netefatso ea Mass Spectrometry ka Electrospray Ionization (ESI-MS) kapa Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) ka ho nepahala ha bongata ka har'a ppSponsors leveraging e amohelehang Liphetoho tsa MOL rua molemo ho molekane ea chesehang ea ikemiselitseng ho bohloeki bo phahameng Peptide Synthesis peptide synthe
Bakeng sa Keletso: Kamehla batla e sa fetoheng, HPLC ea tlhahlobo e tala le lifaele tsa data tsa bongata nakong ea phetisetso ea theknoloji ea CDMO. Ho itšetleha ka Bluum Peptides Laboratory Kakaretso ea litafole tsa CoA ntle le mesaletsa e tala ea chromatographic e ka pata litšila tse kopaneng tse bakang ho hloleha ha batch nakong ea ntlafatso ea bongaka..
botšepehi ba data ho mekhahlelo eohle ea ntlafatso.
Bakeng sa Keletso: Kamehla batla e sa fetoheng, HPLC ea tlhahlobo e tala le lifaele tsa data tsa bongata nakong ea phetisetso ea theknoloji ea CDMO. Ho itšetleha ka kakaretso ea litafole tsa CoA ntle le mesaletsa e tala ea chromatographic ho ka pata litšila tse kopaneng tse bakang ho hloleha ha batch nakong ea ntlafatso ea bongaka..
Lipotso Tse Botsoang Khafetsa (LBH)
Katoloso ea matla ea CDMO ea Tier-1 e ama joang linako tse etellang pele bakeng sa tatelano ea kliniki e seng ea GLP-1??
Hobane li-CDMO tsa Tier-1 li etelletsa pele likonteraka tsa khoebo tsa lithane tse ngata tsa GLP-1 ho holisa ts'ebeliso ea reactor., nako e etellang pele bakeng sa moetlo, tatelano ea kliniki e seng ea GLP-1 ho barekisi ba ka sehloohong e eketsehile ho fihlela likhoeling tse 12-18.. Batšehetsi ba Biopharma ba ka tlola mela ena ka ho sebelisana 'moho le li-CDMO tse khethehileng tsa boemo bo bohareng tse bolokang lisutu tse inehetseng bakeng sa synthesis ea kliniki..
Ke bothata bofe ba mantlha ba ts'ebetso ha u phahamisa li-peptide tsa tloaelo ho tloha ho milligram ho isa ho kilogramme?
Bothata bo ka sehloohong ha se hangata ho ba le lebelo le tiileng la ho kopanya; ke tlhoekiso ea HPLC ea ho itlhoekisa le matla a ho iphelisa. Ha boholo ba batch bo ntse bo eketseha, bohloeki bo sa hloekang bo theoha bakeng sa tatelano e telele kapa ea hydrophobic, e hlokang likholomo tse kholoanyane tse lokiselitsoeng, matla a phahameng a ho hlaphoheloa ha solvent, le lipotoloho tse atolositsoeng tsa ho omisa lihatsetsi ho fihlela bohloeki ba sepheo (≥ 98%).
Joang biopharma R&Lihlopha tsa D li kenya tšebetsong mokhoa o sebetsang oa ho fumana litšebeletso tse peli ntle le ho phahamisa litšenyehelo tsa netefatso?
Ts'ebetso e sebetsang ea li-dual-sourcing e fihlelleha ka ho arola mesebetsi ea tlhahiso ho ipapisitse le sethala sa nts'etsopele le mofuta oa k'hemistri. Barekisi ba "Primary Tier-1" ba sebetsa ka bongata, tlhahiso e tloaelehileng ea API ea khoebo, ha balekane ba bobeli ba khethehileng ba tšoaneleha bakeng sa phepelo ea bongaka ea Mokhahlelo oa I/II, metsoako e rarahaneng ea phetoho, le lihlopha tsa bekapo tsa tšohanyetso. Ho sebelisa mekhoa e hlophisitsoeng ea tlhahlobo tlasa ICH Q2(R1) e fokotsa litšenyehelo tse sa hlokahaleng tsa phetisetso ea theknoloji.
Morero oa Ts'ebetso ea Leano: Ho sireletsa Chain ea hau ea phepelo ea Peptide
H1 e matla ea Bachem 2026 Liphetho tsa lichelete li tiisa hore 'maraka oa lefats'e oa peptide o kena nakong ea kholo e sa lebelloang le matla a lichelete.. Le ha ts'ebetso ena e tiisa matla a ntseng a hola a kalafo ea kalafo ea peptide, e boetse e fana ka matšoao a ho tiea ka ho sa feleng, theko e phahameng haholo, le tikoloho ea tlhahiso ea likonteraka e tsepamisitsoeng haholo.
Biopharma R&Lihlopheng tsa D le batsamaisi ba CMC ha ba khone ho leta feela le ho bona mokhoa oa ho bona. Ho boloka mehato ea lipeipi ho hloka taolo e matla ea kotsi, thuto ea boleng bo holimo, le maano a kopanelo a mabeli.
Ho lekola hore na ke motho ea mahlahahlaha hakae, Sehlopha 100 Molekane ea tiisitsoeng ka kamoreng e hloekileng a ka koala lipeipi tsa hau ho tloha bothateng ba 'maraka, tshoanya Liphetoho tsa MOL kajeno ho hlahloba bokhoni ba tatellano ea moetlo, bokhoni ba ho hlahloba tlhahlobo, le ho boloka bokhoni ba tlhahiso ea bongaka bo phahameng bo hloekileng.
